Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on March 4, 2020. The registrant is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The report addresses a specific corporate event rather than a financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a Current Report on Form 8-K regarding a corporate appointment and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the appointment of John W. Osborn, Ph.D., as a consultant to the Company. Dr. Osborn is a Professor in the Department of Surgery and Director of the Minnesota Consortium for Autonomic Neuromodulation at the University of Minnesota Medical School. This appointment was announced via a press release dated March 4, 2020.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. The document strictly reports the consultant appointment and lists the associated press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the exact scope and terms of the consulting agreement with Dr. John W. Osborn by reviewing the press release filed as Exhibit 99.1.
- Confirm the company name is BioSig Technologies, Inc. (BSGM), as the input metadata referenced "Streamex Corp." which is incorrect based on the filing text.
- Check subsequent filings for any financial impact or strategic updates resulting from this new appointment.